IFF Introduces ENVIROCAP™, a Breakthrough Scent Delivery Technology for Fabric Care
24.7.2025 12:00:00 CEST | Business Wire | Press release
The company’s newest sustainable fragrance innovation is fully ECHA-compliant, biodegradable and vegan-suitable.
IFF (NYSE: IFF), a global leader in flavors, fragrances, and biosciences, has launched ENVIROCAP™ — its newest sustainable scent delivery system designed for the future of fabric care. Developed by IFF’s world-class scientists and fragrance delivery experts, ENVIROCAP™ sets a new standard in innovation: it is fully ECHA-compliant¹, biodegradable² and vegan-suitable³. At the heart of this technology is a proprietary biopolymer that delivers long-lasting fragrance while reducing environmental impact. ENVIROCAP™ not only meets the rising consumer demand for sustainability — it redefines the standard for performance and cost-efficiency.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250724026783/en/
“The launch of ENVIROCAP™ marks a bold new chapter in fragrance encapsulation,” said Ana Paula Mendonça, president, IFF Scent. “In 2005, IFF revolutionized laundry care with scent bursts that brought joy throughout the day. Now, we’re leveraging our leading nature-based bio innovation capabilities to redefine the power of scent technology in laundry — delivering superior sustainability and performance without compromise. With ENVIROCAP™, we aim to support our customers in innovating and bringing true differentiation through elevated sensory impact and sustainability, while delighting consumers with memorable scent experiences.”
The development of ENVIROCAP™ is rooted in IFF’s deep understanding of the consumer’s laundry care journey — from the moment of purchase to the emotional “moment of truth” when freshly washed clothes are experienced for the first time. Around the world, consumers are increasingly seeking sustainable choices and expect brands to take responsibility for designing products with the environment in mind. ENVIROCAP™ directly answers this call. It delivers an uplifting, long-lasting scent experience that enhances freshness from wash to wear — while aligning with the growing demand for eco-friendly, high-performing and value-driven fabric care solutions.
ENVIROCAP™ also allows perfumers great olfactive freedom to harness the virtually limitless possibilities offered by IFF’s extensive fragrance ingredient portfolio. From sparkling citrus to joyful fruity or sensual floral notes and beyond, ENVIROCAP™ works across all stages of the laundry experience — making joy with scent, one laundry cycle at a time.
Learn more about IFF’s delivery systems and encapsulation technologies here.
(1) | Regulation (EU) 2023/2055 of 25 September 2023 amending Annex XVII to EU REACH Regulation (Regulation (EC) No 1907/2006) as regards synthetic polymer microparticles, | |
(2) | According to Biodegradability rules as outlined in the Appendix 15 of the EU Microplastics Restriction, | |
(3) | According to the criteria of the Vegan Society | Certificate available on demand | |
(4) | Mintel, The Future of Fabric Care, 2024 |
Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook.
©2025 International Flavors & Fragrances Inc. IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250724026783/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 15:00:00 CEST | Press release
First-of-its-kind human-to-agent binding service for secure AI-driven commerce, developed with a growing ecosystem of agentic commerce collaborators, including Visa, Cloudflare and Skyfire Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Kn
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 15:00:00 CEST | Press release
New always-on conversational agent with team race intelligence, team insights, and interactive experiences powered by Infobip AgentOS Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant informat
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press release
Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burdenEnpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standardsELOWEN is a global Phase 3 program evaluating enpatoran’s impact on both skin and systemic symptoms in patients with lupus and potential links between skin and systemic disease activity Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People
Riskified Announces 2026 Titans of Ecommerce Award Winners30.4.2026 14:00:00 CEST | Press release
Celebrating the ecommerce leaders from Michael Kors and Gymshark shaping the future of fraud prevention and risk management Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today announced the 2026 Titans of Ecommerce Awards, recognizing outstanding ecommerce leaders who are redefining fraud prevention while driving business growth. The winners are:Titan of Americas: Joseph Chin, Senior Director of Revenue Assurance, Michael Kors Joseph Chin has evolved revenue assurance into a strategic lever for growth at Michael Kors. Deeply knowledgeable in fraud and payments, he maintains a hands-on approach, continually collaborating with Riskified to identify innovative opportunities, optimize performance, and pilot new initiatives. Joseph is highly effective at building internal alignment and securing stakeholder buy-in for new strategies. His leadership shone during Cyber Five, where his close collaboration with Riskified and real-time insights delivered one of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom